| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/18/2008 | CA2680771A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating neuropathy pain |
| 09/18/2008 | CA2680664A1 Compositions and kits for treating influenza |
| 09/18/2008 | CA2680625A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | CA2680600A1 Li-rnai involved li suppression in cancer immunotherapy |
| 09/18/2008 | CA2680560A1 The use of ginsenoside rg1, its metabolites ginsenoside rh1 and/or ppt |
| 09/18/2008 | CA2680527A1 Erythromycin-based macrolides |
| 09/18/2008 | CA2680525A1 Nitroxide radical as a treatment for neurodegeneration |
| 09/18/2008 | CA2680481A1 Intravesical apaziquone administration following transurethral resection for treating cancer |
| 09/18/2008 | CA2680467A1 Inhibitors of histone deacetylase |
| 09/18/2008 | CA2680414A1 Piperidinones useful in the treatment of inflammation |
| 09/18/2008 | CA2680412A1 Piperidinones useful in the treatment of inflammation |
| 09/18/2008 | CA2680405A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 09/18/2008 | CA2680307A1 Monocyclic anilide spirolactam cgrp receptor antagonists |
| 09/18/2008 | CA2680275A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 09/18/2008 | CA2680272A1 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia |
| 09/18/2008 | CA2680249A1 Imatinib mesylate |
| 09/18/2008 | CA2680122A1 Pharmaceutical composition |
| 09/18/2008 | CA2680108A1 Beneficial effects of bacteriophage treatments |
| 09/18/2008 | CA2680029A1 Aminopyrimidines useful as inhibitors of protein kinases |
| 09/18/2008 | CA2679985A1 Malonamides as orexin antagonists |
| 09/18/2008 | CA2679975A1 Therapy for hyperglycemia, related disorders and erectile dysfunction |
| 09/18/2008 | CA2679971A1 Glucokinase activator |
| 09/18/2008 | CA2679884A1 Aminopyrimidines useful as inhibitors of protein kinases |
| 09/18/2008 | CA2679878A1 Pharmaceutical compounds |
| 09/18/2008 | CA2679866A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
| 09/18/2008 | CA2679701A1 Aminopyridines useful as inhibitors of protein kinases |
| 09/18/2008 | CA2679694A1 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | CA2679589A1 Method for production of sugar oxazoline derivative |
| 09/18/2008 | CA2679497A1 Diagnostic and therapeutic aspects of sparc promoter hypermethylation in colon cancer |
| 09/18/2008 | CA2679346A1 Tricyclic isoquinoline derivatives for treatment of obesity |
| 09/18/2008 | CA2679268A1 Treatment of melanoma |
| 09/18/2008 | CA2679210A1 Time- specific delayed/pulsatile release dosage forms |
| 09/18/2008 | CA2678920A1 A medicament for treating chronic obstructive pulmonary disease |
| 09/18/2008 | CA2678897A1 Dibenzo[b,f][1,4]oxazapine compounds |
| 09/18/2008 | CA2678876A1 Orally administrable films |
| 09/18/2008 | CA2677874A1 Amide compounds and their use as antitumor agents |
| 09/18/2008 | CA2677713A1 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 09/18/2008 | CA2677146A1 Novel indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents |
| 09/18/2008 | CA2676981A1 Powders for reconstitution |
| 09/18/2008 | CA2676930A1 Phenylalkylcarboxylic acid delivery agents |
| 09/17/2008 | EP1970438A1 Pasteurisation process for microbial cells and microbial oil |
| 09/17/2008 | EP1970378A1 Photoreactive Ru (II) complexes anchored on oligonucleotides, method for obtaining them and use thereof |
| 09/17/2008 | EP1970377A1 Lincomycin derivative and antibacterial agent containing the same as active ingredient |
| 09/17/2008 | EP1970375A1 Arylmethylene urea derivative and use thereof |
| 09/17/2008 | EP1970374A1 Process for the production of substituted 2-(pyridin-2-ylmethylsulfinyl)-1H-benzimidazoles |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | EP1970372A2 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols |
| 09/17/2008 | EP1970370A1 Amorphous form of 1,2-dihydropyridine compound |
| 09/17/2008 | EP1970366A1 Isohumulone compound clathrate and composition containing the same |
| 09/17/2008 | EP1970078A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 09/17/2008 | EP1970076A1 Pharmaceutical composition for application to nail |
| 09/17/2008 | EP1970075A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 09/17/2008 | EP1970065A1 Anti-infectant carbohydrates |
| 09/17/2008 | EP1970064A1 Silicon-derivatives for pet-imaging |
| 09/17/2008 | EP1970063A1 Therapeutic agent for diabetes |
| 09/17/2008 | EP1970062A1 Novel cxcr4 antagonist and use thereof |
| 09/17/2008 | EP1970061A1 Medicinal agent for treating viral infections |
| 09/17/2008 | EP1970060A2 Use of C-(2-Phenyl-cyclohexyl)-methylamine compounds for fibromyalgia therapy |
| 09/17/2008 | EP1970059A1 Medication with Dobesilat-Calcium for treatment and prophylaxis of tendon disease |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1970057A1 Process for the preparation of stable pharmaceutical compositions of 2-(R) - (1-(R)-(3, 5- bis (trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-(5-oxo-1H, 4H-1, 2, 4-triazolo) methylmorpholine (aprepitant) |
| 09/17/2008 | EP1970056A1 Time-specific delayed/pulsatile release dosage forms |
| 09/17/2008 | EP1970054A2 Clopidogrel tablets |
| 09/17/2008 | EP1970051A1 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 09/17/2008 | EP1970050A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 09/17/2008 | EP1970049A1 Polyaphron topical composition with vitamin D and corticosteroid |
| 09/17/2008 | EP1970048A1 Polyaphron topical composition with vitamin D |
| 09/17/2008 | EP1970047A1 Polyaphron topical composition with a corticosteroid |
| 09/17/2008 | EP1970040A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 09/17/2008 | EP1969951A2 Compositions against inflammatory processes |
| 09/17/2008 | EP1969144A2 Compositions and methods related to controlled gene expression using viral vectors |
| 09/17/2008 | EP1969126A1 Method of detecting and reducing boar taint using nuclear receptors |
| 09/17/2008 | EP1969122A2 Controlling toxicity of aminoquinoline compounds |
| 09/17/2008 | EP1969117A2 A method to treat premature ejaculation in humans |
| 09/17/2008 | EP1969068A2 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 09/17/2008 | EP1968991A1 Bis-platinum complexes with antitumor activity |
| 09/17/2008 | EP1968990A1 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 09/17/2008 | EP1968984A1 Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib |
| 09/17/2008 | EP1968982A2 Thieno (3,2-c) pyridine compounds |
| 09/17/2008 | EP1968981A2 A method of treating tumors with azaxanthones |
| 09/17/2008 | EP1968980A1 Muscarinic receptor antagonists |
| 09/17/2008 | EP1968979A2 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| 09/17/2008 | EP1968978A2 Forms of dolasetron mesylate and processes for their preparation |
| 09/17/2008 | EP1968977A1 Aryl-isoxazol-4-yl-imidazoý1, 5-a¨pyridine derivatives |
| 09/17/2008 | EP1968976A1 Substituted pyrazolo [4,3-c] pyridine derivatives active as kinase inhibitors |
| 09/17/2008 | EP1968975A2 Tylophorine analogs as antitumor agents |
| 09/17/2008 | EP1968972A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 09/17/2008 | EP1968971A1 Dioxolane derivates for the treatment of cancer |
| 09/17/2008 | EP1968970A2 Processes for the preparation of alfuzosin |
| 09/17/2008 | EP1968969A2 Organic compounds |
| 09/17/2008 | EP1968968A1 Compositions and methods for modulating gated ion channels |
| 09/17/2008 | EP1968967A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 09/17/2008 | EP1968966A1 Inhibitors of ccr9 activity |
| 09/17/2008 | EP1968963A1 Substituted propiolic acid amides and their use for producing analgesics |
| 09/17/2008 | EP1968962A2 Diaza heterocyclic sulfonamide derivatives and their uses |
| 09/17/2008 | EP1968961A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2008 | EP1968959A2 Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |